ZILBRYSQ
NDC 50474-992, zilucoplan, injection, solution, from UCB, Inc..
- Product NDC
- 50474-992
- Status
- Listed
- Labeler
- UCB, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216834
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50474-992 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZILUCOPLAN40 mg/mL
Pharmacologic classes
Complement Inhibitor [EPC]; Complement Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50474-992-80 | 50474099280 | 4 CARTON in 1 BOX (50474-992-80) / 7 SYRINGE, GLASS in 1 CARTON / .81 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9f1d53d6-e495-4a3a-8bb9-680a15d25034
Use it
Look up 50474-992 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50474-992 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50474-992. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.